Zinc, copper, and iron were measured in the pleural fluid of 86 patients with benign conditions (including congestive heart failure, pulmonary embolus, collagen disease, pneumonitis, nonspecific pleuritis, and tuberculosis) and in 116 patients with malignant disease (including lymphoma, breast carcinoma, primary lung cancer, and metastatic lung cancer). Though a positive correlation was found between zinc and copper in the benign group and not in the malignant group, the test was not specific enough to differentiate benign from malignant disease, because of the wide scatter of results.
A positive regression for serum copper on pleural fluid copper was found in the benign, lymphoma, and malignant groups, but the differences between these three were not sufficient to help in the differential diagnosis.
These findings suggest that pleural fluid heavy metals do not have the specificity that has been reported for serum heavy metals in benign and malignant disease and in malignant lymphoma.
Earlier studies have shown that the serum copper is elevated in Hodgkin's lymphoma, tuberculosis, and neoplastic disease and that in the latter the serum iron is decreased.
The present study was designed to show whether the zinc, copper, and iron contents of pleural fluid could help to identity the cause of the effusion.
METHOD
Zinc, copper, and iron concentrations were measured by atomic absorption spectrometry. The solutions to be analysed were aspirated directly after eliminating the viscosity effect by dilution with glass-distilled water.
RESULTS
Two groups were studied-86 patients with benign disease and 116 patients with malignant disease.
The diagnoses in the benign group (Table I ) included congestive heart failure (17), collagen disease (15), hypoalbuminaemia (13), pulmonary embolus (10), 'pneumonitis' (9), nonspecific (Table II) .
DISCUSSION
Recently, there has been much interest in the concentrations of trace metals occurring in human and animal tissues and in the manner in which these concentrations may alter in malignant and other disease states (Parr and Taylor, 1964) . Szmigielski and Litwin (1964) described decreased values of zinc in acute and chronic granulocytic leukaemia, Hodgkin's disease, and plasma-cell leukaemia, and a decreased zinc content in blood granulocytes in other neoplastic disease states. Schrodt, Hall, and Whitmore (1964) (Nielsen, 1944; Van Ravesteyn, 1944) . Serum copper (Holmberg and Laurell, 1947) is found in the a2-globulin fraction of the serum, and patients with neoplastic disease have been found to have an increase in a2-globulins in the serum. One other explanation for the observed hypercupraemia may lie in the reduced demand for copper, an essential catalyst in haemoglobin synthesis. There is no evidence, however, to indicate that hypercupraemia is related to alterations in erythropoiesis (Lahey et al., 1953) .
In previous studies of copper metabolism normal subjects have provided material for control measurements. All pleural effusions are abnormal so no control values are possible. In our study a positive regression was found for serum copper on pleural fluid copper in the benign and malignant groups, with the highest slope in the lymphoma group, the next highest in the malignant group, and the lowest in the benign group. There were several relationships between pleural fluid variables in the benign group which were not present in the malignant group. This was true for the relationships between protein on the one hand and copper, zinc, and iron on the other, and it was also true for the relationship between copper and zinc. 
